SAN MATEO, Calif., June 4, 2010 (GLOBE NEWSWIRE) — Pain Therapeutics, Inc.
(Nasdaq:PTIE) today announced that management will present at the Needham
Healthcare Conference in New York City on Wednesday, June 9th at 4:00 p.m.
The presentation will be webcast live and may be accessed from the home page of
Pain Therapeutics’ website at www.paintrials.com. A replay of the webcast will
continue to be available on the website for up to 90 days.
About Pain Therapeutics, Inc.
Pain Therapeutics, Inc. is a biopharmaceutical company that develops novel
drugs. In addition to REMOXY(R), a unique abuse-resistant controlled-release
oxycodone, the company has three drug candidates in clinical programs, including
a novel radio-labeled monoclonal antibody to treat metastatic melanoma, as well
as PTI-202 and PTI-721. Pain Therapeutics is also working on a new treatment for
patients with hemophilia.
CONTACT: Pain Therapeutics, Inc.
Judy Ishida, Administrative Manager